PSTV:NASDAQ
Plus Therapeutics Inc
$4.13
arrow_downward
-4.18%(-0.18) 1D
Jun 18, 11:56:04 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PSTV...
Open
$4.34
High
$4.38
Low
$4.10
Mkt. cap
28.56M
Avg. vol.
150.89K
Volume
100.61K
52-wk high
$23.42
52-wk low
$2.90
EPS
-$2.50
Beta
1.38
Shares outstanding
6.88M
No. of employees
28
Open
$4.34
High
$4.38
Low
$4.10
Mkt. cap
28.56M
Avg. vol.
150.89K
Volume
100.61K
52-wk high
$23.42
52-wk low
$2.90
EPS
-$2.50
Beta
1.38
Shares outstanding
6.88M
No. of employees
28
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to PSTV in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PSTV in the last 3 months.
Highest
Current $4.13
$65.00 (+1,473.85%)
Average
$42.33 (+924.94%)
Lowest
$12.00 (+190.56%)
News stories
From sources across the web
Profile
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
About Plus Therapeutics Inc
AI content may include mistakes. Learn more